US EditionFirefly uncovers powerful new method of measuring SCD, MCI, and dementia in Alzheimer’s disease - BioTuesdays
Summary by biotuesdays.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Alzheimer's disease is a complex disease that can only be partially prevented even with a healthy diet. US researchers have isolated a promising active ingredient from a well-known kitchen herb.
Firefly uncovers powerful new method of measuring SCD, MCI, and dementia in Alzheimer’s disease - BioTuesdays
Firefly Neuroscience (NASDAQ: AIFF) has announced a significant advancement in Alzheimer’s disease research: the company has identified a novel, objective method for measuring and distinguishing between subjective cognitive decline (SCD), mild cognitive impairment (MCI), and dementia in Alzheimer’s disease. This breakthrough enables a scalable and accessible approach to promote earlier detection and intervention. In the study, while EEG/ERP and …
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
